Sg Americas Securities, LLC Instil Bio, Inc. Transaction History

Sg Americas Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$0.6 - $0.91 $1,413 - $2,143	2,356 Added 9.22%	27,905 $18,000
Q4 2022 Feb 02, 2023	BUY	$0.48 - $5.33 $1,135 - $12,610	2,366 Added 10.21%	25,549 $16,000
Q3 2022 Oct 31, 2022	SELL	$4.65 - $7.37 $17,242 - $27,327	-3,708 Reduced 13.79%	23,183 $112,000
Q2 2022 Jul 29, 2022	BUY	$4.21 - $11.15 $113,211 - $299,834	26,891 New	26,891 $124,000
Q1 2022 Apr 29, 2022	SELL	$8.48 - $18.1 $75,226 - $160,565	-8,871 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$15.37 - $22.5 $136,347 - $199,597	8,871 New	8,871 $152,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.82B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.